What were the wins and losses for women in the industry during the past year, and what is their outlook for the coming year? We wanted a real-time assessment from the people most affected by those questions — women executives. The advocacy group, Women In Bio, backed by LifeSci Advisors, helped us recruit leading women in biopharma companies and organizations to share their views of women’s current state of progress and the prospects for short-term change in the industry.
In all, we hear from 11 women and one man in biopharma. Although we were not aiming for “balance” here — there are plenty of opposing opinions out there already — the sole gender-exception in this group supplies another valuable viewpoint, that of a man working hard to help other men see the world the way women in biopharma often see and encounter it.